Esthesioneuroblastoma: Outcomes After Treatment

NCT ID: NCT02580136

Last Updated: 2021-02-11

Basic Information

• Recruitment Status: WITHDRAWN
• Study Classification: OBSERVATIONAL
• Study Start Date: 2015-09-30
• Study Completion Date: 2021-02-08

Brief Summary

The purpose of this study is to collect and organize data into a repository to gather relevant information for future research from patients diagnosed with a rare malignant sinonasal cancer called esthesioneuroblastoma (ENB) and are scheduled to undergo endonasal skull base surgery. Data being collected includes surgical data, demographics, disease presentation, MRI, CT, PET imaging, and post-operative assessments including pathology tests. After surgery, the investigators will collect chemotherapy and radiation data. Participants will also complete quality of life questionnaires at their follow-up visits.

Conditions

Esthesioneuroblastoma, Olfactory

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• Between the age of 10-80 years
• Diagnosed with esthesioneuroblastoma

Exclusion Criteria

• Refusal to participate

• Minimum Eligible Age: 10 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Ricardo L. Carrau, MD

OTHER

Sponsor Role: lead

Responsible Party

Ricardo L. Carrau, MD

Ricardo L. Carrau, MD

Responsibility Role: SPONSOR_INVESTIGATOR

Principal Investigators

Ricardo Carrau, MD

Role: PRINCIPAL_INVESTIGATOR

Ohio State University

Locations

The Ohio State University

Columbus, Ohio, United States

Countries

United States

Other Identifiers

2015C0066

Identifier Type: -

Identifier Source: org_study_id